February 2 is observed as Rheumatoid Arthritis Awareness Day to raise awareness about the condition, its causes, symptoms, treatment options, and more ...

World Rheumatoid Arthritis Day is observed every year on February 2. It is an autoimmune condition that attacks the joints ...

World Rheumatoid Arthritis Day on February 2, 2025, is a powerful reminder of the importance of understanding rheumatoid ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

Rheumatoid arthritis is an autoimmune condition that causes the body’s immune system to attack its own joints, leading to ...

Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...

Many people mistakenly assume that joint pain is simply a natural part of ageing, often overlooking RA as a potential cause.

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.